This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Merck: Operating Science-Based Business
-
Reference: HBS-612082-E
-
Year: 2004
-
Number of pages: 13
-
Geographic Setting: United States
-
Publication Date: Apr 23, 2012
-
Fecha de edición: May 9, 2012
-
Source: HBSP (USA)
-
Type of Document: Case
-
Industry Setting: Pharmaceuticals
Description
Merck is known for its commitment to investing in basic R&D. Are Merck's long-term investments justifiable when the firm faces extreme earnings pressure?